Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures muted as oil holds near April highs ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| INSMED (NASDAQ: INSM) | Delayed: 93.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.33 | 52 Week High | $19.30 | |||
| Open | $93.33 | 52 Week Low | $9.02 | |||
| Day High | $93.33 | P/E | N/A | |||
| Day Low | $93.33 | EPS | $-1.69 | |||
| Volume | 636 | |||||
